Physician profile
Helen C Hall
NPI 1679908768
$9,161.51
in general payments reported to CMS, 2019-2025
31 companies · $270 in 2025
The $270 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,873 · 2020: $656 · 2021: $794 · 2022: $558 · 2023: $473 · 2024: $538 · 2025: $270.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,200 · Gift: $40.92 · Travel and Lodging: $40.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,199.66 |
| Gift | $40.92 |
| Travel and Lodging | $40.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,842.86 | 2019-2025 | Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,327.76 | 2019-2023 | Vistaseal |
| Medtronic, INC. | $454.44 | 2021-2024 | Interstim |
| Axonics, INC. | $409.21 | 2021-2024 | Axonics, Bulkamid |
| Ethicon US, LLC | $346.32 | 2019-2024 | Harmonic, Endopath, Echelon Circular |
| Davol INC. | $344.98 | 2019-2025 | Channel Drain |
| Braintree Laboratories, INC. | $159.54 | 2021-2023 | Sutab, Suflave |
| Medtronic USA, INC. | $138.46 | 2020 | |
| Agiliti Surgical, INC. | $122.09 | 2022 | |
| Cook Medical LLC | $110.67 | 2019-2020 | |
| Acell, INC. | $100.00 | 2019 | |
| Olympus America INC. | $97.72 | 2019 | |
| Baxter Healthcare | $97.61 | 2019-2022 | |
| Palette Life Sciences, INC. | $77.02 | 2021 | |
| Tetraphase Pharmaceuticals, INC. | $73.23 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $69.36 | 2022-2024 | Irrisept |
| Acacia Pharma INC | $52.14 | 2021-2022 | |
| La Jolla Pharmaceutical Company | $48.62 | 2023 | Xerava |
| Merck Sharp & Dohme LLC | $45.67 | 2020-2021 | |
| Pacira Pharmaceuticals Incorporated | $40.97 | 2022-2023 | Exparel |
| Coopersurgical, INC. | $30.96 | 2021 | |
| Smith+Nephew, INC. | $29.79 | 2023 | Grafix |
| Kerecis Limited | $22.55 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Boston Scientific Corporation | $16.68 | 2025 | Bulkamid |
| Covidien LP | $15.94 | 2020 | |
| Innocoll Pharmaceuticals Limited | $15.72 | 2021 | |
| Tela Bio, INC. | $15.62 | 2022 | |
| Integra Lifesciences Corporation | $15.41 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.99 | 2020 | |
| Avanos Medical | $13.10 | 2019 | |
| Stryker Corporation | $13.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Helen Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.